Juniper Pharma Services Expands Granulation Capabilities

News   Oct 21, 2016

 
Juniper Pharma Services Expands Granulation Capabilities
 
 
 

RELATED ARTICLES

Diabetes Drug Could Be Re-purposed to Help End Transplant Rejection

News

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs.

READ MORE

Study Shows Cancer Patients Are Choosing Less Severe Side Effects Over Treatment Efficacy

News

When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a new study.

READ MORE

Apple Allergens as an Effective Option for Treating Apple Allergy

News

Researchers have now proven in a Phase II trial that the apple allergen "Mal d 1" significantly reduces the symptoms of apple allergy and is therefore an effective and safe treatment option.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE